📊 **Technical Analysis for Glenmark Pharmaceuticals (NSE)**
**Current Price:** ₹1,518.15 **Resistance:** ₹1,545.60 (Upper boundary of the rejection zone) **Support:** ₹1,439.95 & ₹1,420.55 (Key levels marked with a purple zone)
---
### 🔍 **Analysis Details:** 1. **Bearish Setup:** - Glenmark is trading below the **50-day Moving Average**, which indicates a bearish trend. - A recent breakdown occurred from a consolidation range, which suggests downside momentum.
2. **Key Support Zone:** - The highlighted **purple support box** between ₹1,440 and ₹1,420 acts as a strong demand zone. - If the price breaches ₹1,508 (current support), we expect it to retest the lower support levels.
3. **Stop-Loss and Targets:** - **Entry:** Below ₹1,508 (confirmation of weakness). - **Stop-Loss (SL):** ₹1,545.60 (above the rejection zone to limit risk). - **Target (TGT):** ₹1,439 and ₹1,420 (major support levels).
4. **Risk-to-Reward:** - If executed below ₹1,508, the **Risk-to-Reward Ratio** is favorable, providing potential downside gains while limiting losses.
5. **Trend Confirmation:** - The blue arrow in the chart signals a **bearish continuation** toward the support levels, aligning with current market weakness.
Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.